Pharma brand positioning is unique due to many reasons. Pharma marketing refers to the digital and offline strategies used to attract new patients and increase awareness around a specific drug or treatment plan. Segmentation can be the key to to increase Sales Force effectiveness but this in itself must be achieved in line with the modern mantra of âdo more with lessâ. Behavioristic Segmentation. In companies Iâve worked in, there is sometimes a segmentation âkeeperâ the go-to person who keeps the segmentation study up to date. Behavioristic segmentation is defined by differences in consumption behavior within a group or market. Building bridges to better access. by Mel Sokotch February 21, 2018. ... patient group or even a pharmaceutical. Where fine-tuned patient segmentation might prove most useful, practitioners say, is in designing care management for chronic illness. Patient segmentation techniques are very powerful. First, the decision maker of choosing a brand is the HCP and the end user is the patient. In terms of marketing strategy, itâs important to identify the most suitable audience and know the difference between them. Regarding the market for pharmaceutical outsourcing, a market segmentation analysis can be performed when separating companies via the phase of drug development companies are in when choosing an outsourcing partner. Twitter. Second Thoughts On Patient Segmentation Studies. Itâs also a piece of work that informs all engagement activity. Segmentation is something that must live within an organizational team. The first, patient-focused approach recognises that, even if they are all suffering from the same condition, patients have varying needs. With the patent cliff behind them, pharma drug manufacturers are looking to pick-up momentum and find other ways to hone their competitive edge. Pharma marketing can either be geared towards physicians (the lionâs share of the market) or towards selling directly to consumers. A patient population thick with "out and abouts," then, might welcome the onsite integrative therapies that Massachusetts General Hospital offers its oncology patients. Pharma marketers have two audiences â patients and doctors. company site, ⦠And effective programs leverage various and unique coaching methods, messaging, and communication channels to influence patients across each segment. According to Malcolm MacKenzie, senior VP, strategic planning/business development, Juice Pharma Worldwide, the current focus is to invest heavily in segmentation studies and other quantitative research and this short changes an important aspect of patient understanding. Most pharma companies continue to use a pretty traditional approach, identify segments based on how valuable that customer is to the brand, based primarily on scripts written, current value, with perhaps an element of potential value thrown in for good measure, usually by evaluating the size of the patient pool for each customer. Linkedin; The enduring appeal that high-priced segmentation research holds for pharmaceutical marketers is difficult to understand. It is a live document, that needs to be updated, kept relevant etc. Facebook. Traditionally, most pharma marketers have tried to manage the heterogeneity of the market in two ways; patient segmentation or prescriber segmentation. In the non-pharma world, a segmentation study can be extremely helpful, and can help you narrow your gaze to a laser focus on the unmet needs of the most valuable target audience. Second, the pharma market is a cluttered branded generic market where given a molecule there are no less than 80 to ⦠Keywords segmentation, pharmaceutical e-business, Internet, market segmen tation, customer relationship management.